BNET Industries

  • Public
  • US
Dow Jones Description

The Company has developed, marketed, distributed and supported a diversified mix of products and services for the telecommunications industry. Over the past 15 years, the Company developed expertise in real-time wireless call processing and created technologically advanced solutions for this industry, focusing primarily in the area of wireless communications fraud management, geo-location wireless software applications and sales of prepaid long-distance phonecard products. On November 9, 2002, CTS ceased development efforts of its Neumobility development project, and on December 11, 2002 adopted a plan to wind down the operations of its Isis Tele-Communications, Inc. subsidiary. As a result, CTS has no current business other than to complete the wind-down of the operations of Isis. Management currently has no plan to liquidate the Company and distribute the remaining assets to stockholders. During 2002, 2003 and to date, management has been and will continue evaluating alternative businesses and acquisitions.

Vice President, Chief Financial Officer
Bruce R York
Contact Information

20 East Sunrise Highway

Suite 200

Valley Stream, New York 11581

516-568-0100

NAICS Code Cellular and Other Wireless Telecommunications: 517212

Decision Makers

Name (plus bio) Position
Bruce R York Vice President, Chief Financial Officer
Barry J Beil Director
Dr. Phillip Frost Director
Joshua J Angel Director
Lawrence Schoenberg Director
Richard C. Pfenniger Director

Board of Directors

Name (plus bio) Position
Stephen Katz Chairman of the Board of Directors
Steven D. Rubin Board of Directors

Organization Position Status
Cellular Technical Services Co, Inc. Vice President, Chief Financial Officer Current

Organization Position Status
Cellular Technical Services Co, Inc. Chairman of the Board of Directors Current

Organization Position Status
Cellular Technical Services Co, Inc. Director Current

Phillip Frost, M.D. Dr. Frost became the CEO and Chairman of OPKO Health, Inc. upon the consummation of the merger of Acuity Pharmaceuticals Inc., Froptix Corporation and eXegenics, Inc. on March 27, 2007 (referred to as the Acquisition ). Dr. Frost was named the Vice Chairman of the Board of Teva Pharmaceutical Industries, Limited (NasdaqGS:TEVA), or Teva, in January 2006 when Teva acquired IVAX Corporation, or IVAX. Dr. Frost had served as Chairman of the Board of Directors and Chief Executive Officer of IVAX Corporation since 1987. He was Chairman of the Department of Dermatology at Mt. Sinai Medical Center of Greater Miami, Miami Beach, Florida from 1972 to 1986. Dr. Frost was Chairman of the Board of Directors of Key Pharmaceuticals, Inc. from 1972 until the acquisition of Key Pharmaceuticals by Schering Plough Corporation in 1986. Dr. Frost was named Chairman of the Board of Ladenburg Thalmann Financial Services Inc. (NYSE Amex: LTS), an investment banking, asset management, and securities brokerage firm providing services through its principal operating subsidiary, Ladenburg Thalmann & Co. Inc., in July 2006 and has been a director of Ladenburg Thalmann since March 2005. Dr. Frost also serves as Chairman of the Board of Directors of Ideation Acquisition Corp., a special purpose acquisition company formed for the purpose of acquiring businesses in digital media (NYSE Amex: IDI), Modigene Inc., a development stage biopharmaceutical company (OTCBB: MODG), and Castle Brands, a developer and marketer of premium brand spirits (NYSE Amex: ROX). He serves on the Board of Regents of the Smithsonian Institution, as a member of the Board of Trustees of the University of Miami, a Trustee of each of the Scripps Research Institutes, the Miami Jewish Home for the Aged, and the Mount Sinai Medical Center. Dr. Frost is also a director of Continucare Corporation, a provider of outpatient healthcare and home healthcare services (NYSE Amex: CNU), and Northrop Grumman Corp., a global defense and aerospace company (NYSE: NOC).

Organization Position Status
Opko Health, Inc. CEO Current
Peregrine Ventures | Terms & Conditions General Partner & Investment Committee Member Current
University of Miami Trustee Current
The Scripps Research Institute Trustee Current
Ladenburg Thalmann Financial Services Inc. Chairman of the Board of Directors Current
Pzk Chairman Current
Opko Health, Inc. Chairman Current
Modigene Inc. Chairman of The Board of Directors Current
Ideation Acquisition Corp. Chairman of the Board of Directors Current
Ladenburg Thalmann & Co., Inc. Director Current
Cellular Technical Services Co, Inc. Director Current
Protalix Biotherapeutics, Inc. Board of Directors Current
Continucare Corporation Director Current
The Regents Board of Directors Current
The American Stock Exchange LLC Member, Board of Governors Current
Castle Brands Inc. Board of Directors Current
Peregrine Ventures | Terms & Conditions Board of Directors Current
IVAX Diagnostics, Inc. Board of Directors Current
The Frost Group Board of Directors Current
Teva Pharmaceutical Industries Ltd. Vice Chairman of the Board of Directors Current
Northrop Grumman Corporation Board of Directors Current
Continucare Corporation Vice Chairman, Board of Directors Current
IVAX Corporation CEO Former
IVAX Corporation President Former
IVAX Corporation Chairman, Board of Directors Former
University of Miami Chairman, Board of Trustees Former
Teva Pharmaceutical Industries Ltd. Chairman, Board of Directors Former
Modigene Inc. Board of Directors Former
Ladenburg Thalmann Financial Services Inc. Board of Directors Former
Albert Einstein College M.D. Former
The American Stock Exchange LLC member Former

Organization Position Status
Cyrus Capital Management Current
Cellular Technical Services Co, Inc. Director Current
Lancer Industries Inc. Director Current
The CattleSale Company Director Current
Columbia University Llb Former
New York University B.S. Degree Former

Organization Position Status
Cellular Technical Services Co, Inc. Director Current

Organization Position Status
Continucare Corporation Chief Executive Officer Current
Continucare Corporation President Current
Opko Health, Inc. Chairman Current
Continucare Corporation Chairman of the Board Current
Cellular Technical Services Co, Inc. Director Current
GP Strategies Corporation Board of Directors Current
General Physics Corporation Board of Directors Current
IVAX Corporation Chief Operating Officer Former
IVAX Corporation Senior Vice President Former
Legal Affairs Senior Vice President Former
IVAX Corporation General Counsel Former
Opko Health, Inc. Director Former

Organization Position Status
Opko Health, Inc. President, Administration Current
Opko Health, Inc. Executive Vice President Current
Neovasc Medical Chairman of the Boards of Directors Current
Neovasc Inc. Chairman of The Boards of Directors Current
Opko Health, Inc. Director Current
Ideation Acquisition Corp. Secretary Current
Dreams Inc. Board of Directors Current
Cellular Technical Services Co, Inc. Board of Directors Current
Neovasc Inc. Board of Directors Current
Medical Ventures Corp. Board of Directors Current
The Frost Group Board of Directors Current
Telergy Senior Vice President Former
Telergy General Counsel Former
Stearns Weaver Miller Weissler Alhadeff & Sitterson Former
B-Balloon Ltd. Chairman of the Boards of Directors Former
Telergy Secretary Former
B-Balloon Ltd. Director Former
University of Florida J.D. Degree Former
Tulane University B.A. Former
Neovasc Medical Board of Directors Current

Executive News

  • Continucare Corporation Reports 52% Increase in Net Income for Fourth Quarter of Fiscal 2009

    DiGiTAL50 - 9/10/09 - View Story

  • Continucare Corporation Reports 52% Increase in Net Income for Fourth Quarter of Fiscal 2009

    Business Wire - 9/10/09 - View Story

  • Continucare Corporation Reports 52% Increase in Net Income for Fourth Quarter of Fiscal 2009

    Stockwatch - 9/10/09 - View Story

  • Continucare acquires sleep centers

    Biz Journals - 8/13/09 - View Story

  • Continucare acquires sleep centers

    South Florida Business Journal - 8/13/09 - View Story

  • Opko narrows losses

    Biz Journals - 8/10/09 - View Story

advertisement
advertisement